The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo Nordisk rolled out the first GLP-1 ...

The FDA-approved weight loss drug offers an oral alternative to invasive injections with similar effectiveness.

The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks.

A 12-week program that home-delivered medically tailored groceries and provided diabetes self-management education and support materials led to a clinically meaningful reduction in A1c levels among ...

H-bridge buck-boost ICs are widely used in applications requiring a constant voltage or current source even when the system battery drops to lower voltages. They make sense when a single-stage ...

The Boost brand and the ADA are urging action for early detection of diabetes. Joshi added, "Supporting the American Diabetes Association reinforces our mission to empower individuals with the ...

The MarketWatch News Department was not involved in the creation of this content. Together, the BOOST (R) Brand and the ADA are Raising Awareness and Inspiring Action for Early Detection of Diabetes ...

An experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice and human cells. When you purchase through links on our site, we may earn ...

Oct 3 (Reuters) - ChatGPT creator OpenAI will soon introduce controls allowing the owners of content rights to dictate how their characters are used in its AI video-generating tool Sora and plans to ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape, but ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...